5 terminated. 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Terminated 5 |
Follow Meningitis: new trials by email Literature Review of Meningitis trials Research Report on Meningitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treatment of West Nile Virus With MGAWN1 MGAWN1, Placebo - normal saline - West Nile Neuroinvasive Disease, West Nile Virus Infection | Phase 2 | Terminated | MacroGenics | 13 | 2009-05-01 | 2022-02-10 |
| Study Evaluating Safety, Tolerability, and Immunogenicity of Meningococcal B Vaccine in Healthy Infants meningococcal B rLP2086 vaccine, Routine age appropriate childhood vaccines - Meningitis, Meningococcal | Phase 2 | Terminated | Pfizer | 46 | 2009-01-01 | 2014-11-26 |
| Efficacy and Safety of Mycograb as Adjunctive Therapy for Cryptococcal Meningitis in Patients With AIDS Mycograb, placebo - Cryptococcal Meningitis | Phase 2 | Terminated | Novartis Pharmaceuticals | 3 | 2007-03-01 | 2008-12-12 |
| Efficacy and Safety of Mycograb as Adjunctive Therapy for Cryptococcal Meningitis in Patients With AIDS Efungumab (Mycograb), placebo, Amphotericin B - Cryptococcal Meningitis | Phase 2 | Terminated | Novartis Pharmaceuticals | 38 | 2006-08-01 | 2009-02-19 |
| Antibody Responses Following Meningococcal Tetravalent (A, C, Y, and W-135) Conjugate Vaccination in Healthy Adults Meningococcal Polysaccharide Diphtheria Toxoid Conjugate - Meningitis, Meningococcemia | Phase 2 | Terminated | Sanofi Pasteur, a Sanofi Company | 18 | 2004-01-01 | 2014-02-14 |
Meningitis, Cryptococcal (2) · Encephalitis (1) · Meningitis, Meningococcal (1) · Meningococcal Infections (1) · West Nile Fever (1) · acute flaccid myelitis (1)
Infections (5) · Nervous System Diseases (5) · Neuroinflammatory Diseases (5) · Bacterial Infections and Mycoses (4) · Central Nervous System Diseases (4) · Central Nervous System Infections (4) · Bacterial Infections (2) · Central Nervous System Fungal Infections (2) · Cryptococcosis (2) · Gram-Negative Bacterial Infections (2) · Meningitis, Fungal (2) · Mycoses (2) · Neisseriaceae Infections (2) · Arbovirus Infections (1)
efungumab (2) · Amphotericin B (1) · Flucytosine (1) · Meningococcal Vaccines (1)
Novartis Pharmaceuticals (2) · MacroGenics (1) · Pfizer (1) · Sanofi Pasteur, a Sanofi Company (1)
South Africa (1) · Spain (1) · United Kingdom (1) · United States (1)
2008 (1)